SEPARATION AGREEMENT AND RELEASESeparation Agreement • October 27th, 2021 • Checkmate Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledOctober 27th, 2021 Company Industry JurisdictionThis Separation Agreement and Release (this “Agreement”) is made between Checkmate Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Barry Labinger (the “Executive”). The Company together with the Executive shall be referred to as the “Parties”.